Tag Archive for: CBD

NIHC and A2LA Partner for Hemp Product Safety

The National Industrial Hemp Council of America (NIHC) accepts A2LA ISO/IEC 17025 accreditation for entry into the A2LA-NIHC Verify Joint Hemp/Cannabis Recognition Program as part of their approval process for their NIHC Verify program for hemp testing laboratories. This program allows the hemp testing laboratories that are ISO/IEC 17025 A2LA Accredited and NIHC members to be recognized under
the NIHC Verify program.

The A2LA-NIHC Verify Joint Hemp/Cannabis Recognition Program requires the applicant laboratory to adhere to the requirements applicable in A2LA R101 – General requirements for accreditation of ISO/IEC 17025 laboratories and A2LA normative documents R103, R105, and P102.

The goal of A2LA-NIHC Verify Joint Hemp/Cannabis Recognition Program is to promote testing transparency, standards requirements, consumer confidence, and ultimately product safety.

This program was developed to establish a benchmark for hemp testing laboratories that are accredited to conduct the following testing (at a minimum):

  • Pesticides
  • Heavy Metals
  • Potency
  • Microbiology
  • Residual Solvents

This program is covered by the A2LA chemical and biological fields of testing.

Program Requirements
ISO/IEC 17025 General requirements for the competence of testing and calibration laboratories
Specific Requirements – A2LA-NIHC Verify Joint/Hemp Cannabis Recognition Program

Please contact A2LA for more information on this accreditation at: agouker@A2LA.org

##

About NIHC 

The National Industrial Hemp Council of America provides high-quality networking and resources for its members, from farm to consumer. Its leadership is composed of leading international, federal, state, private industry, and government professionals throughout the sector. The organization is dedicated to furthering market development, assisting members in entering the industry, and educating consumers on industrial hemp and its applications. For more information, please go to www.nihcoa.com.

WASHINGTON, D.C. – The Safety Equipment Institute, an affiliate of ASTM International, and the National Industrial Hemp Council of America (NIHC) announced today they have signed a memorandum of understanding (MOU) to develop a joint certification program for hemp testing laboratories. This initiative will lead to industry harmonization and embed confidence of hemp brands promoting consumer health and safety.

“We’re excited for this program that we believe will strengthen consumer confidence and be a value add for hemp producers. Partnering with SEI and ASTM International, who have a rich history in certification and standardization, should make for an excellent partnership.” said Patrick Atagi, President and CEO of the National Industrial Hemp Council of America.

“ASTM international is the world leader in developing cannabis standards and we are proud to partner with NIHC to administer this program to fill a marketplace need,” says Tricia Hock, Director of Certification Operations with the Safety Equipment Institute. “This effort coincides with the work of ASTM International’s cannabis committee (D37) which includes over 1000 members from 32 different countries. We believe delivering a joint certification program for hemp testing laboratories is a critical first step in harmonizing the hemp industry.”

The certification program, known as ASTM International’s CANNQ/HEMPQ Certification Program, is the first independent certification of its kind in the hemp and cannabis industry.  The testing laboratory certification program is part of a broader collaborative initiative among the Safety Equipment Institute and the National Industrial Hemp Council of America.

ASTM International is a not-for-profit nongovernmental organization that develops voluntary consensus standards and defers to appropriate government authorities to determine the legal and regulatory framework regarding the control and use of cannabis.

To learn more about ASTM International’s efforts in the cannabis space, visit www.astmcannabis.org.

About NIHC

The National Industrial Hemp Council of America provides high-quality networking and resources for its members, from farm to consumer. Its leadership is composed of leading international, federal, state, private industry, and government professionals throughout the sector. The organization is dedicated to furthering market development, assisting members in entering the industry, and educating consumers on industrial hemp and its applications. For more information, please go to www.nihcoa.com.

About ASTM International

Committed to serving global societal needs, ASTM International positively impacts public health and safety, consumer confidence, and overall quality of life. We integrate consensus standards – developed with our international membership of volunteer technical experts – and innovative services to improve lives… Helping our world work better.

WASHINGTON, D.C. – The National Industrial Hemp Council (NIHC) announced today, at its 2021 Hemp Business Summit, plans to roll out a pilot program establishing standards for product testing protocols and laboratories. Participants in the program will be able to label products with the NIHC label of approval, ensuring the accuracy of product labeling that will set standards for ingredients, ensure the accuracy of labeling and ultimately, strengthen consumer confidence in the cannabidiol (CBD) products that they’re buying. 

The announcement, made during the standards panel discussion, comes one day before NIHC will hear directly from the U.S. Food and Drug Administration (FDA) Cannabis Product Committee Chair, Grail Sipes, at its meeting tomorrow. 

“We’re excited for this program that we believe is going to strengthen consumer confidence, promote accuracy in labeling and ultimately, protect the brand of hemp,” said Patrick Atagi, President and CEO of the National Industrial Hemp Council. “Since the passage of the 2018 Farm Bill, consumers have been waiting for the FDA to act on CBD. Without any guidance from the FDA thus far, NIHC is stepping up to develop our own testing standards and labeling protocols that we believe will enhance consumer safety and protect the consumer’s right to know.”

NIHC believes in establishing an accurate, consistent testing regime. This label will bring value to the marketplace and integrity to products sold nationwide in stores and online. NIHC is exploring testing standards and third-party verification laboratory requirements that will be applicable when testing for potency, pesticides, metals, terpenes, and other product attributes. A critical part of the program will include using third-party accreditation bodies to verify that laboratories are following the appropriate testing protocols and properly calibrating their equipment, and that those running the tests are properly trained. 

“As one of North America’s leading food and consumer product testing companies, FSNS is pleased to lead this effort,” said Barry Carpenter, NIHC Board member, NIHC Standards Committee Chair, and Senior Advisor for Regulatory Affairs and Client Relations for Food Safety Net Services (FSNS). “This initiative will bring value to the marketplace and peace of mind to the consumer with reliable and transparent information about CBD products.”

NIHC is looking to partner and explore these standards with the world’s leading standards bodies, hoping to make a pilot program for CBD companies and labs available for enrollment. 

With NIHC developing its own standards and label, consumers looking to buy CBD products, at either brick-and-mortar retail stores or online, will have an opportunity to look for an NIHC label that ensures products that they’re considering purchasing meet the most stringent safety protocols in the hemp industry.

About the National Industrial Hemp Council: The National Industrial Hemp Council provides high-quality networking and resources for its members, from farm to consumer. Its leadership is composed of leading international, federal, state, private industry, and government professionals throughout the sector. The organization is dedicated to furthering market development, assisting members in entering the industry, and educating consumers on industrial hemp and its applications.

WASHINGTON – The National Industrial Hemp Council today submitted comments to Senator Cory Booker (D-NJ); U.S. Senate Finance Committee Chairman Ron Wyden (D-OR); and Senate Majority Leader Chuck  Schumer (D-NY) on their proposed draft of the Cannabis Administration and Opportunity Act (CAOA).

“NIHC appreciates Majority Leader Schumer, Chairman Wyden and Senator Booker for their thoughtful and forthright outreach on the CAOA,” said NIHC President and CEO Patrick Atagi. “Though we believe the bill requires further work and revision in several key respects, this proposal is among the most comprehensive and far-reaching treatments of Federal cannabis legalization to date and the sponsoring offices have gone above and beyond to solicit feedback on this important and complex policy issue.”

The highlights of NIHC’s comments to Senator Booker, Chairman Wyden and Majority Leader Schumer are:

  1. Rather than vesting authority for licensing cannabis cultivation in the Treasury Department, NIHC encourages the Sponsoring Offices to consider vesting this authority in the Department of Agriculture instead, while reserving the involvement of Treasury, Justice and FDA for taxation and public health and safety when cannabis products enter the marketplace, as with tobacco, wine grapes, etc.
  2. The bill should revise the Federal definition of hemp by specifying the threshold in terms that are complementary to what it provides for cannabis, with a threshold of one percent total concentration of tetrahydrocannabinols rather than the current parameter of 0.3 percent for only delta-9 THC.
  3. The provisions relating to cannabidiol (CBD) should reflect the approach taken in Senator Wyden’s own S. 1698, by allowing all hemp-derived products, including CBD, as both food and supplement.  The draft legislation which proposes to allow only CBD, with no provision for other hemp-derived products that are not intoxicating or otherwise subject to abuse, and would allow CBD only as supplements and not as food.
  4. The tax structure proposed in the bill is too onerous and severely disadvantages small and minority-owned businesses, which will promote rather than reduce illicit production.

“Though NIHC identifies several specific issues requiring careful further attention, and do not doubt that our colleagues in the high-THC cannabis industry do so as well, we believe this draft covers most if not all pertinent issues that Federal regulation of cannabis will have to address,” Atagi continued. “Though our organization does not engage in high-THC cannabis, we believe that our industry’s experience in the Federal regulation of hemp to date is replete with lessons learned that will be of great value as Congress and stakeholders chart a course to the future of cannabis regulation in our country.”

You can read NIHC’s full comments to the sponsoring offices of the Cannabis Administration and Opportunity Act below.

 

[embeddoc url=”https://hempindustrial.com/wp-content/uploads/2021/09/NIHC-comment-on-CAOA.pdf” download=”all” viewer=”google”]

Hall of Fame Football Coach Lou Holtz took football powerhouse, Notre Dame, from a 5-6 win/loss record in 1985 to a National Championship three years later. Incredibly enough, he is maybe even better known as a world renowned motivational speaker. One great quote from Coach Holtz stands out and is always relevant. He said, “I never learn anything talking. I only learn things when I ask questions.” It’s particularly relevant as NIHC advocates on behalf of the industry.

Last week we wrote to you about some of the highlights from the draft Cannabis Administration and Opportunity Act (CAOA) unveiled by Senate Majority Leader Chuck Schumer (D-NY) and Senators Corey Booker (D-NJ) and Ron Wyden (D-OR). We raised some of what we thought were interesting questions

As the Capitol and Congress opens their door for discussion on this draft bill, NIHC has been walking congressional halls in-person. We’ve been meeting with Members of Congress and their staff this past week. Like Lou Holtz, the NIHC is asking questions to lawmakers, as well as industry stakeholders, on the hemp-related provisions of the CAOA. The more we engage in Washington, the more questions we had about the bill, the more it’s leading us to ask more detailed questions.

What we wrote in last week’s e-newsletter bears repeating. Hemp policy is complicated. A cookie-cutter approach doesn’t work. We’ve learned over the last three years that the regulatory scheme that governs the hemp crop doesn’t keep pace with industry innovation and how consumers use our product. That leads to a myriad of unintended consequences including a lack of transparency that should inform the end users of our crop and products.

On that note, we are soliciting industry, consumer, grower, and retailer input. Have you read the Schumer-Booker-Wyden bill? What are your thoughts? What stands out to you? What do you see as a concern?

As we continue to engage Washington, it’s helpful to hear feedback from our members and industry partners. We have a lot of work to do, so please take time to read the bill and share your thoughts with our government affairs committee at info@hempindustrial.com.

Comments on the bill are due back to the sponsors of the legislation by September 1.

Read the NIHC Press Release on CAOA.

Consumer Brands Releases White Paper on CBD

The Consumer Brands Association this week released a white paper on CBD policy with some interesting statistics. Of the consumers polled on CBD, 74% of respondents either incorrectly assumed that CBD was regulated or didn’t understand that CBD was not yet regulated by the FDA.

On a scale of one to ten, consumers admitted their knowledge on CBD and CBD products was only at a collective score of 3.3.

The results of the Consumer Brands Association/Ipsos poll that interviewed 1,000 consumers showed similar results to a benchmark poll conducted by the same two organizations in December of 2019. In that poll, 40% of respondents believed CBD was another name for marijuana while 51% believed that CBD had an intoxicating effect.

The poll further solidifies NIHC’s belief in the need for more consumer education about CBD and hemp-derived products. Consumer education would be a key component to the checkoff program that the NIHC is currently pursuing with other industry stakeholders.

For more information, you can read the press release and the full paper from the Consumer Brands Association.

If you pay attention to cannabis policy and follow its progress on Capitol Hill, this week was an exciting week for our industry. It’s been long-rumored that Senate Majority Leader Chuck Schumer (D-NY), Senator Corey Booker (D-NJ) and Senator Ron Wyden (D-OR) would be introducing the Cannabis Administration and Opportunity Act (CAOA) – legislation to decriminalize marijuana. At NIHC, we don’t have as much to say about that as our cousins in the high-THC business do; but we are certainly minding its portents for the hemp industry. There’s a lot to love in the bill, and many questions too.

The co-sponsors of this bill released their legislation in draft form which means that it hasn’t been formally introduced. NIHC applauds this as a smart and strategic approach that embodies the hard lessons we’ve all learned about the complexities and pitfalls of hemp policy by releasing a draft form of the legislation and seeking industry feedback. As we all know, hemp and higher-THC derivatives are extremely complicated, particularly when regulatory authorities are trying to catch up to industry innovation and we’re operating off of a state-by-state patchwork of laws. Therefore, we much appreciate this approach from the sponsors, and NIHC will continue to engage lawmakers and provide input on the many technical provisions of the bill that relate both directly and indirectly to the hemp industry.

At first glance, the draft legislation contains many positive elements, but it also understandably raises a significant number of technical questions that require careful consideration. We’re hopeful that our history of navigating the regulatory challenges over the last three years and the feedback that we can provide will be a value-add to the entire hemp industry, because there are many important things to consider.

For instance, the draft legislation would allow hemp-derived CBD as a dietary supplement. But it would not explicitly allow other hemp products, as does the bill introduced earlier this summer by Senator Wyden along with Senators Merkley and Paul. The draft legislation introduced this week also would not allow for the inclusion of CBD to be an ingredient to food as the Merkley-Wyden-Paul bill does. So as an industry, we need to work through those differences by soliciting feedback from you and determine the best course of action going forward.

Another curiosity coming out of CAOA is the mandate for ‘cannabis’ (meaning high-THC cannabis and excluding hemp) cultivation to be administered by the Treasury Department, in connection with ATF/TTB authority that will be extended to cannabis. What will it be like for hemp cultivation to be administered by one Department (USDA), and high-THC cannabis cultivation to be administered by another? How will the two coordinate, and what opportunities and pitfalls might our respective industries encounter? Much to ponder.

Meanwhile, another element that appears promising is the bill’s provision for ‘hot’ hemp crops (over the THC limit) to be eligible for diversion into the cannabis value chain. While we all appreciate the sponsors’ evident intent to take another opportunity to help hemp farmers mitigate their risk of hot crops, we should be clear-eyed in recognizing that this may be of little solace. There would likely be little value to hemp farmers who already have extremely low THC in their crops in a market where high THC potencies are the stock in trade.

By far the simplest and most expedient way to relive hemp farmers of the risk of ‘hot’ crops is to change the Federal definition of hemp from an upper limit of 0.3% delta9-THC to one that limits the concentration of all tetrahydrocannabinols to 1%, as many stakeholders have long advocated (including, as of February 2021, 45 State Agriculture Commissioners). And, by the way, it’s worth noting that the CAOA’s removal of all tetrahydrocannabinols from the Controlled Substances Act further supports the need for such a change. NIHC continues to work on this very closely with key Members in the Senate and House; watch this eNewsletter for more developments.

There are many other questions for our industry to consider and, to be frank, our NIHC staff and government affairs co-chairs Rick Fox of Meristem Farms and Jeff Sands of Columbia Care are still parsing through the bill to identify technical issues, provide feedback to Hill staff, and contemplate new questions that arise. Be on the lookout in next week’s newsletter for an in-depth interview with Rick Fox after we’ve had time to parse the individual provisions in the 167-page bill.

Regardless, we’re going to need your input. You can view the 20-page factsheet here and read the text of the legislation by clicking on the hyperlinks. It’s important to take the time to review this draft and let us know your thoughts. Please email your comments to info@hempindustrial.com if you find something that is concerning to you or if you identify items that you believe need to be addressed.

Have a great weekend and happy reading! We look forward to hearing from you.

FOR IMMEDIATE RELEASE

July 14, 2021

CONTACT:  Larry Farnsworth, (703) 489-9633

 

WASHINGTON – The National Industrial Hemp Council (NIHC) Board Chair Patrick Atagi released the following statement after the Cannabis Administration and Opportunity Act was released in draft form by Senate Majority Leader Chuck Schumer (D-NY), Senator Corey Booker (D-NJ) and Senator Ron Wyden (D-OR): 

“On first glance, the draft contains many positive elements, and we’re pleased the approach of the sponsors is to solicit technical input before releasing final legislation.  The accumulated experience of the hemp industry and its regulators over several years of navigating the tribulations of hemp policy will surely offer important insights as this legislation and subsequent regulations are developed, refined and implemented.  

“Right now, hemp farmers around the country struggle with a patchwork of state and Federal laws because technical details and regulatory uncertainty have created confusion for the hemp industry at all levels of government.  We hope this draft legislation will begin an opportunity for our industries to build and improve upon the experience of Federal regulation in hemp to promote consumer safety and transparency, to level the playing field for farmers and growers, and to create workable regulatory delineations and pathways so that businesses of all shapes and sizes can flourish while redeeming the promise of this new yet ancient crop. Indeed, the plants from which we make our products are cousins—hemp and marijuana are plants of the same species Cannabis sativa L.—and so too are our respective industries-distinct, but similar.  

“The NIHC will continue reviewing the draft of this legislation, working with our membership in the hemp industry to provide feedback to lawmakers on Capitol Hill, and bringing our many lessons learned from the tribulations of hemp regulation. The NIHC believes we can work collaboratively with our counterparts in the high-THC cannabis industry toward realizing a sound regulatory vision for the future of legal cannabis in all its forms.” 

 

About the National Industrial Hemp Council: The National Industrial Hemp Council provides high-quality networking and resources for its members, from farm to consumer. Its leadership is composed of leading international, federal, state, private industry, and government professionals throughout the sector. The organization is dedicated to furthering market development, assisting members in entering the industry, and educating consumers on industrial hemp and its applications. For more information please go to www.hempindustrial.com.

 

# # #

 

 

 

As an avid reader of NIHC’s weekly newsletter, you’ll no doubt note that recently we included an item in the news section about the U.S. House of Representatives Subcommittee on Agriculture Appropriations draft report language on hemp.

There was much to celebrate:

  • A prohibition on the use of funds in contravention of the hemp provisions in both the 2014 Farm Bill and 2018 Farm Bill. This adds needed clarity that hemp produced under 2014 Farm Bill authorities remains fully legal under Federal law.
  • Another extension of the 2014 Pilot Program—through the end of 2022—for the approximately 75% of the hemp farming that operates under these authorities, including four of the five largest hemp producing states.
  • Direction to the USDA, HHS and the DEA to study the scientific basis of the 0.3 percent THC threshold and consider alternative levels.
  • Direction to USDA to reduce barriers to access for communities of color, specifically citing the 10-year ban on individuals convicted of drug felonies as such a barrier.
  • Clear acknowledgment that Congress intended to avoid criminalization of hemp processing, understands that in-process extract may temporarily exceed the THC limit, and directs USDA to coordinate directly with the DEA to present the industry with guidance and information on in-process extracted material
  • Eligibility of hemp to participate in all USDA-related programming. This includes the value-added producer grants program through the Office of Rural Development, crop insurance through the Risk Management Agency and as a specialty crop through the Agriculture Marketing Service (AMS).

The NIHC has been working with the House Committee on Agriculture to provide feedback on many of these roadblocks facing farmers in our industry. We have directly spoken to members of Congress and their staff on both sides of the aisle to raise awareness about all of the things that were mentioned in the Subcommittee on Agriculture Appropriations report. We are continuing to engage with members and staff of both parties on both sides of the Capitol.

This week, we sent a letter to House Agriculture appropriators thanking them for their language in this report and circulated it to those on the authorizing committees and also friends of the hemp industry.

You can read the full letter sent from NIHC Board Chair Patrick Atagi to the House Committee on Agriculture here.

Shawn Hauser discusses the Hemp Road Traveled and the Road of Infrastructure Ahead

 

Shawn Hauser is partner in Vicente Sederberg LLP, as well as chair of the firm’s Hemp and Cannabinoids Department, where she helps cannabis and hemp businesses navigate the intersection – and often collision – between state and federal law. Her practice helps companies comply with hemp laws, food and drug laws, regulations and licensing, as well as provides them general business representation. “This is unique to our practice,” says Hauser. “By providing clients compliance guidance with state hemp and cannabis laws and an understanding of how cannabis laws may evolve, we help guide them into a more stable and successful future.”

Hauser has been in the cannabis space for almost 12 years. “After graduating from college at the University of Texas, I had a passion to get involved with cannabis reform. I come from multi-generations of psychiatrists who have been dedicated to mental health care, and understood that cannabis is often a safer and more effective treatment to treat many mental health conditions, but that the law needed to change to allow doctors to utilize and understand cannabis as medicine.”

Hauser came to Colorado in 2008 in the early days when caregivers of patients who were receiving medical cannabis treatment lacked a supporting legal system. “I began work on the legalization campaign when I met the partners from McAllister, Darnell & Gottlieb PC who were also working on the issue. They built the firm around it in 2010 and I joined as an associate attorney,” Hauser says. The firm was one of the first marijuana-focused law firms in Colorado.

In 2013, Hauser joined Vicente Sederberg where she continued her work. The firm set out to help shape laws that would work to create a responsible cannabis industry and included hemp. “In 2012, founders of the law firm were key drafters of Colorado’s Amendment 64 which legalizes marijuana possession for adults under state law and requires the state to establish a regulatory structure for retail marijuana. In that framework, we included the state legalization of industrial hemp.”

From that foundation, the firm has built a thriving hemp practice, which grew exponentially with the passage of 2018 Farm Bill. “In the hemp department, we do a great deal of policy work all over the country in addition to legal services, such testifying to the FDA as to the regulation of CBD, advising states in how to regulate hemp-derived cannabinoids in FDA’s absence, and addressing best practices for consumer safety,” says Hauser. “One of our goals is to see the FDA step up. We are passionate to ensure that hemp products are regulated appropriately and responsibility, and appreciate that the federal regulation of hemp sets the table for how all cannabis may be most appropriately regulated.”

 

“One of our goals is to see the FDA step up. We are passionate to ensure that hemp products are regulated appropriately and responsibility, and appreciate that the federal regulation of hemp sets the table for how all cannabis may be most appropriately regulated.”

 

“We do a lot of work with other industry stakeholders and have key alliances that complement our regulatory practice, such as our close alliance with Kleinfeld, Kaplan and Becker,” says Hauser of the Washington D.C.-based law firm who focuses their practice on Food & Drug Law and Advertising Law.

In the meantime, while all that comes to fruition, the firm helps clients navigate the patchwork of state regulations for cannabis and hemp. There are a lot of moving parts and complicated federal, state, and local laws relevant to setting up an industrial hemp or cannabis-based business.

“Usually, a client comes to us because they are in hemp supply chain, as a farmer, retailer or brand, and they want to know how to be compliant at the federal level in the light of the Farm Bill, as well as with the FDA and within the complexity of state laws,” says Hauser. She notes that businesses have more to consider than a normal business. They must set up proper corporate entities, negotiate contracts, ensure that business insurance is adequate (watching for exclusions unique to the industry), review marketing materials including product packaging and labeling, develop products within tight legal parameters, complete various safety studies, manage ingredients properly, set up proper production and supply and distribution chains that are complaint, and mitigate the unique risk inherent in the cannabis industry. There are also the environmental laws to be followed, especially on industrial hemp production. It is quite complex.

“The good news is that Colorado continues to serve as a model state for others to follow,” says Hauser. “We are leading the way in hemp. Our governor has done an outstanding job to help us get leaps ahead from when we started. We have a level of infrastructure, agency expertise, and informed and effective rulemaking processes that is unparalleled, with state leadership and industry dedicate to having the most responsible and effective robust hemp program. Governor Polis has organized stakeholder groups for every aspect. Top universities and ag folks are quickly taking things to next level. We are bolstering state industrial hemp companies through incentives to build processing facilities in Colorado to make things like concrete and hemp plastics, all game changing for the planet and industry.”

Once the federal framework is complete, Hauser sees the U.S. as a major market on the world hemp stage. But the road to accomplishing this is slowly working its way out in equalizing state to state in the rules for production and sale of consumer products, and in developing the infrastructure and research needed to support a true industrial hemp industry. “Hemp having varying sets of rules for production and sale state to state is one the industry’s biggest barriers. The failure of the FDA to effectively regulate products leaves an emerging market without regulation to guide it,” she says.

“Right now, with CBD and consumable hemp product regulations, many states regulations conflict with federal law, but federal law is generally not enforced absent companies making serious drug claims,” says Hauser. It makes it difficult for states to enforce, creates unique legal exposure to businesses who follow federal lay but violate state law or vice versa. It also makes investors leery, creating banking and insurance conflicts.

In the future that Hauser is advocating for she sees a healthier hemp world. “I see federal legalization and development of a vibrant U.S. cannabis and hemp industry that includes broader acceptance of cannabis as medicine and as an alternative to alcohol, as well as a healthy dietary supplement, ingredient in foods and cosmetics as appropriate, and a natural alternative to more harmful ingredients currently used. Hemp is revolutionary and can be used in animal feed, plastics, fuel, all kinds of products. It can have a role in reversing climate change. There are so many uses, we have only seen the tip of the iceberg.”

If you’ve been following our work, you know that we’ve been pushing for commonsense and sensible regulations from Food and Drug Administration (FDA) for cannabidiol (CBD).

And like you, we’ve been waiting.

Congress has sought to act and fulfill the role of the FDA by legislating. Earlier this Congress, Congressman Kurt Schrader (D-CO) along with Morgan Griffith (R-VA) and 18 other original bipartisan co-sponsors introduced legislation that would make CBD lawful for use as a supplement unless otherwise directed by the FDA. The bill has been referred to the House Energy and Commerce Committee where it has yet to have a hearing.

This week, Senators Ron Wyden (D-OR), Rand Paul (R-KY) and Jeff Merkley (D-OR) introduced the Hemp Access and Consumer Safety Act that would deem CBD not only as a supplement, but also as an additive in food. The Senate bill introduced this week also puts a premium on safety and transparency by requiring manufacturers to comply with all FDA regulations and products be labeled properly.

 

“CBD products are legally being used and produced across the nation. Yet because the FDA has failed to update its regulations, consumers and producers remain in a regulatory gray zone.”


– Senator Ron Wyden (D-OR)

 

“CBD products are legally being used and produced across the nation. Yet because the FDA has failed to update its regulations, consumers and producers remain in a regulatory gray zone,” Senator Wyden said. “It’s been more than two years since I worked with colleagues to have Congress legalize hemp and hemp-derived products. It’s long past time for the FDA to get with the program, for the sake of American consumers and farmers.”

“Hemp-derived CBD products and businesses have earned their recognition in the marketplace, but the FDA, unfortunately, hasn’t treated them like any other food additive or dietary supplement,” Dr. Paul said. “The Hemp Access and Consumer Safety Act directs the FDA to regulate hemp products properly and provides a huge relief to hemp farmers, processors, and merchants.”

“Every day that the FDA drags its feet to update its CBD regulations, hemp farmers are left guessing about how their products will be regulated, and real economic gains for workers and business owners in Oregon and across the country are left on the table,” said Senator Merkley upon introduction. “Hemp-derived CBD products are already widely available, and we all need FDA to issue clear regulations for them just like they do for other foods, drinks, and dietary supplements.”

NIHC has been supportive of this effort in the Senate and has provided significant input into this legislation. Upon the introduction of the bill, NIHC Board Chairman Patrick Atagi pointed to how this legislation won’t just ensure consumer safety but also could stimulate considerable economic growth.

“Last year, nearly $15 billion in economic benefits were left out of the economy because CBD wasn’t regulated appropriately. If the FDA can’t act, Congress should fulfill its oversight role and pass this legislation,” said Atagi. “NIHC supports Senators Merkley, Paul and Wyden’s recognition of hemp and CBD as an ingredient in both food and supplements, and we applaud their legislative approach to ensure that it’s regulated accordingly.  This bill will deliver safe products to the marketplace and create a hemp economy that works for everyone.”

So, there are now two different bills in Congress. One in the House that is supplements only and one in the Senate that affirms CBD as both a supplement and food. NIHC supports both bills and prefers the approach from Senators Wyden, Merkley and Paul, primarily because it includes food and thus provides more opportunities for farmers and the largest segment of the hemp/CBD market. We also prefer how the Senate bill would effect this change by affirming that hemp and hemp-derived CBD is legally distinct from the previously FDA-approved pharmaceutical that contains CBD. It remains to be seen what will happen with these two bills since we’re just getting started in this process – but you can rest assured NIHC will be at the table and providing input into the process.

You can read the full text of the Hemp Access and Consumer Safety Act here.

 

Tag Archive for: CBD

Nothing Found

Sorry, no posts matched your criteria

National Industrial Hemp Council of America
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.